EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

FMRP and CYFIP1 at the Synapse and Their Role in Psychiatric Vulnerability

Nicholas E Clifton, Kerrie L Thomas, Lawrence S Wilkinson, Jeremy Hall, Simon Trent

Complex Psychiatry · 2020 · 6 (1-2) · 5-19

DOI: 10.1159/000506858 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Complex Psychiatry, online erschienen am 03.03.2020. Verfasst von Nicholas E Clifton und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience & Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is increasing awareness of the role genetic risk variants have in mediating vulnerability to psychiatric disorders such as schizophrenia and autism. Many of these risk variants encode synaptic proteins, influencing biological pathways of the postsynaptic density and, ultimately, synaptic plasticity. Fragile-X mental retardation 1 (FMR1) and cytoplasmic fragile-X mental retardation protein (FMRP)-interacting protein 1 (CYFIP1) contain 2 such examples of highly penetrant risk variants and encode synaptic proteins with shared functional significance. In this review, we discuss the biological actions of FMRP and CYFIP1, including their regulation of (i) protein synthesis and specifically FMRP targets, (ii) dendritic and spine morphology, and (iii) forms of synaptic plasticity such as long-term depression. We draw upon a range of preclinical studies that have used genetic dosage models of FMR1 and CYFIP1 to determine their biological function. In parallel, we discuss how clinical studies of fragile X syndrome or 15q11.2 deletion patients have informed our understanding of FMRP and CYFIP1, and highlight the latest psychiatric genomic findings that continue to implicate FMRP and CYFIP1. Lastly, we assess the current limitations in our understanding of FMRP and CYFIP1 biology and how they must be addressed before mechanism-led therapeutic strategies can be developed for psychiatric disorders.

Schlagwörter

Stichwörter der Autor:innen

Cytoplasmic FMRP-interacting protein 1Fragile-X mental retardation proteinFragile-X mental retardation protein targetsPsychiatric disordersSynapse

Autor:innen und Institutionen

  • Neuroscience & Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom.
  • MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • School of Biosciences, Cardiff University, Cardiff, United Kingdom.
  • School of Psychology, Cardiff University, Cardiff, United Kingdom.
  • Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • School of Life Sciences, Faculty of Natural Sciences, Keele University, Keele, United Kingdom.

Förderung

  • Medical Research Council

Zitieren

APA

Clifton, N. E., Thomas, K. L., Wilkinson, L. S., Hall, J., & Trent, S. (2020). FMRP and CYFIP1 at the Synapse and Their Role in Psychiatric Vulnerability. Complex Psychiatry, 6(1-2), 5-19. https://doi.org/10.1159/000506858

Vancouver

Clifton NE, Thomas KL, Wilkinson LS, Hall J, Trent S. FMRP and CYFIP1 at the Synapse and Their Role in Psychiatric Vulnerability. Complex Psychiatry. 2020;6(1-2):5-19. doi:10.1159/000506858

BibTeX
@article{Clifton2020,
  author = {Clifton, Nicholas E and Thomas, Kerrie L and Wilkinson, Lawrence S and Hall, Jeremy and Trent, Simon},
  title = {FMRP and CYFIP1 at the Synapse and Their Role in Psychiatric Vulnerability},
  journal = {Complex Psychiatry},
  year = {2020},
  volume = {6},
  number = {1-2},
  pages = {5--19},
  doi = {10.1159/000506858}
}
Kostenlos starten →